Eugene Fan

This inventor holds 18 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Pacific Biotech, Inc., Academia Sinica, Wyntek Corporation. Active years: 1989-2015.

USPTO Granted Patents = 18

% Patents Active = 83.3

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 3.6

ph-index = 14

Forward Citations = 1,084(Granted Patents)

Company Filing History:

8 out of 9

Pacific Biotech, Inc.

Wyntek Diagnostics, Inc.

8. 1 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 1989-2015

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9149458 - [object Object] (2015-10-06),

2. 8486914 - [object Object] (2013-07-16),

3. 7947283 - [object Object] (2011-05-24),

4. 7785600 - Compositions and methods for treating allergies, auto-immune diseases, and improving skin condition by ganoderma lucidum (reishi) polysaccharides (2010-08-31),

5. 7666614 - [object Object] (2010-02-23),

6. 6979576 - Methods of use of one step immunochromatographic device for Streptococcus A antigen (2005-12-27),

7. 6368876 - One step immunochromatographic device and method of use (2002-04-09),

8. 6194221 - Hybrid one-step immunochromatographic device and method of use (2001-02-27),

9. 5763262 - Immunodiagnostic device (1998-06-09),

10. 5712172 - One step immunochromatographic device and method of use (1998-01-27),

11. 5223220 - Solid phase immunoassay device and method of making same (1993-06-29),

12. 5182191 - Occult blood sampling device and assay (1993-01-26),

13. D328135 - Reaction unit for use in analyzing biological fluids (1992-07-21),

14. 5096837 - Immunochromatographic assay and method of using same (1992-03-17),

15. 5096809 - Whole blood assays using porous membrane support devices (1992-03-17),

Title: **The Innovative Contributions of Inventor Eugene Fan**

Introduction

Eugene Fan is a notable inventor based in La Jolla, California, recognized for his significant contributions in the field of biomedicine. With a remarkable portfolio of 18 patents, he has been instrumental in advancing technologies aimed at improving health outcomes.

Latest Patents

Among his latest innovations, one patent stands out for its potential impact on treating hypertriglyceridemia. This invention details a method for addressing this condition using a specific composition that includes wedelolactone, luteolin, and apigenin. Additionally, the patent outlines a method to reduce the risk of developing hypertriglyceridemia by administering the composition to at-risk subjects. Another significant patent from Eugene focuses on compositions derived from mycelia extracts, which include chromatographically separated polysaccharide-enriched fractions. This invention offers methods for extracting mycelia and describes applications in the amelioration, prevention, and treatment of sepsis, acute endotoxemia, and inflammatory responses.

Career Highlights

Eugene Fan has had a commendable career with notable roles in various companies. He has worked at Pacific Biotech, Inc. and Wyntek Corporation, where he contributed his expertise in biotechnological advancements. His work has evidenced a commitment to innovation and the application of scientific research to real-world problems.

Collaborations

Throughout his career, Eugene has collaborated with respected peers, including Ching Huang and Fon-Chiu M. Chen. These collaborations have enriched his work and expanded the reach of his innovative solutions in the medical field.

Conclusion

Eugene Fan continues to make significant strides in innovation through his patents and collaborations. His work not only reflects his dedication to advancing biomedical technologies but also emphasizes the importance of teamwork in achieving groundbreaking results. As he continues to develop new solutions, the impact of his inventions will likely resonate in the healthcare industry for years to come.